[1]
|
R. Barth, et al., "Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption," Cancer Research, vol. 57, p. 1129, 1997.
|
[2]
|
R. F. Barth, et al., "Neutron capture therapy of intracerebral melanoma: enhanced survival and cure after blood-brain barrier opening to improve delivery of boronophenylalanine," Int J Radiat Oncol Biol Phys, vol. 52, pp. 858-68, Mar 1 2002.
|
[3]
|
C. H. Hsieh, et al., "Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption," J Nucl Med, vol. 46, pp. 1858-65, Nov 2005.
|
[4]
|
T. M. Allen and P. R. Cullis, "Drug delivery systems: entering the mainstream," Science, vol. 303, pp. 1818-22, Mar 19 2004.
|
[5]
|
C. R. Dass, et al., "Enhanced anticancer therapy mediated by specialized liposomes," J Pharm Pharmacol, vol. 49, pp. 972-5, Oct 1997.
|
[6]
|
D. F. Deen, et al., "Brain Tumor Working Group Report on the 9th International Conference on Brain Tumor Research and Therapy. Organ System Program, National Cancer Institute," J Neurooncol, vol. 16, pp. 243-72, Jun 1993.
|
[7]
|
R. J. Motzer, et al., "Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors," J Natl Cancer Inst, vol. 85, pp. 1828-35, Nov 17 1993.
|
[8]
|
R. J. Motzer, et al., "High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors," J Clin Oncol, vol. 15, pp. 2546-52, Jul 1997.
|
[9]
|
R. K. Puri, et al., "Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL4-Pseudomonas exotoxin chimeric protein," Int J Cancer, vol. 58, pp. 574-81, Aug 15 1994.
|
[10]
|
H. Y. Hong, et al., "Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis," J Cell Mol Med, vol. 12, pp. 2003-14, Oct 2008.
|
[11]
|
X. L. Wu, et al., "Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy," Bioconjug Chem, vol. 21, pp. 208-13, Feb 17 2010.
|
[12]
|
J. H. Kim, et al., "Facilitated intracellular delivery of peptide-guided nanoparticles in tumor tissues," J Control Release, Sep 16 2011.
|